Researchers have demonstrated that roxadustat promotes angiogenesis through activation of the HIF-1α/VEGF/VEGFR2 pathway in STZ-induced DM rats, which indicates that roxadustat has a certain therapeutic effect on the healing of DM wounds (Zhu et al., 2019). The gene discussed is HIF1A; the disease is diabetes mellitus.